And other news from Christians around the world.

Scientists have resurrected a strange seed that was discovered in a cave in the Judean desert during the 1980s. According to ...

For 14 years, scientists have been growing a tree akin to the Judean balsam — the source of the balm of Gilead — but with no modern counterpart. For 14 years, scientists have been growing a ...

Which makes it likely you’re looking for safe and natural ways to treat these muscles aches. For muscle aches and pains, Tiger Balm is a well known herbal preparation which pregnant women may want to ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The best cat trees ward off boredom for our feline friends by providing indoor playgrounds ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead's stock has surged due to successful launches of Livdelzi for PBC and promising developments in lenacapavir for HIV prevention. Livdelzi's approval and strong market potential, combined ...

This vinyl is available for pre-order at Juno, for shipping on the release date. You won’t be charged until the order is despatched. We'll keep you informed of your order at every stage, and let you ...

Details are thin on the ground, but we know Gilead is tapping into Terray’s so-called tNova platform, the startup’s generative AI. This platform is designed to improve the speed, cost and ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of $105.00. Discover top-rated stocks from ...

The festive White House Christmas Tree in Washington, DC. The theme for this year's holiday decorations is “Season of Peace and Light.” Photo by Anna Moneymaker. From the “most famous” (a ...

Gilead Sciences (GILD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...